Author + information
- Received November 3, 2000
- Revision received February 26, 2001
- Accepted March 14, 2001
- Published online June 15, 2001.
- Takayoshi Tsutamoto, MDa,* (, )
- Atsuyuki Wada, MDa,
- Tetsuya Matsumoto, MDa,
- Keiko Maeda, MDa,
- Naoko Mabuchi, MDa,
- Masaru Hayashi, MDa,
- Takashi Tsutsui, MDa,
- Masato Ohnishi, MDa,
- Masahide Sawaki, MDa,
- Masanori Fujii, MDa,
- Takehiro Matsumoto, MDa,
- Takashi Yamamoto, MDa,
- Hajime Horie, MDa,
- Yoshihisa Sugimoto, MDa and
- Masahiko Kinoshita, MDa
- ↵*Reprint requests and correspondence: Dr. Takayoshi Tsutamoto, First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu 520-2192, Japan
This study evaluated oxidative stress in the failing ventricle in patients with dilated cardiomyopathy (DCM).
Oxidative stress appears to increase in the failing myocardium and may contribute to ventricular dysfunction in patients with DCM. Tumor necrosis factor-alpha (TNF-alpha), which is expressed in the failing heart, may stimulate oxidative stress.
We measured plasma oxidized low density lipoprotein (oxLDL) by sandwich enzyme-linked immunosorbent assay using specific antibodies against oxLDL in the aortic root (AO) and the coronary sinus (CS) in control subjects (n = 8) and in 22 patients with DCM and mild congestive heart failure. We also measured the plasma levels of TNF-alpha and angiotensin II.
There was no difference in oxLDL between the AO and CS in control subjects. In contrast, plasma oxLDL was significantly higher in the CS than the AO in patients with DCM, suggesting that the transcardiac gradient of oxLDL reflects oxidative stress in the failing heart in these patients. Plasma TNF-alpha levels were significantly higher in the CS than the AO with a significant positive correlation of the transcardiac gradient of TNF-alpha and the transcardiac gradient of oxLDL. Moreover, a significant negative correlation existed between the transcardiac gradient of oxLDL and left ventricular ejection fraction. The transcardiac gradient of plasma oxLDL was significantly lower in 6 patients who received carvedilol than in 16 patients who did not receive carvedilol.
These findings indicate that the transcardiac gradient of oxLDL may be a marker of oxidative stress in the heart and that left ventricular dysfunction may be partly due to the oxidative stress in patients with DCM. In addition, TNF-alpha may stimulate oxidative stress in the failing heart in patients with DCM.
☆ This study was supported by a Japanese Grant-in-Aid for Scientific Research.
- Received November 3, 2000.
- Revision received February 26, 2001.
- Accepted March 14, 2001.
- American College of Cardiology